Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 15 February 2002:
Vol. 295. no. 5558, pp. 1311 - 1314
DOI: 10.1126/science.1067236
Prev | Table of Contents | Next

Reports

A Class of Potent Antimalarials and Their Specific Accumulation in Infected Erythrocytes

Kai Wengelnik,1 Valérie Vidal,2 Marie L. Ancelin,1 Anne-Marie Cathiard,1 Jean Louis Morgat,3 Clemens H. Kocken,4 Michèle Calas,2 Socrates Herrera,5 Alan W. Thomas,4 Henri J. Vial1*

During asexual development within erythrocytes, malaria parasites synthesize considerable amounts of membrane. This activity provides an attractive target for chemotherapy because it is absent from mature erythrocytes. We found that compounds that inhibit phosphatidylcholine biosynthesis de novo from choline were potent antimalarial drugs. The lead compound, G25, potently inhibited in vitro growth of the human malaria parasites Plasmodium falciparum and P. vivax and was 1000-fold less toxic to mammalian cell lines. A radioactive derivative specifically accumulated in infected erythrocytes to levels several hundredfold higher than in the surrounding medium, and very low dose G25 therapy completely cured monkeys infected with P. falciparum and P. cynomolgi.

1 CNRS UMR 5539, CP 107,
2 CNRS UMR 5810, CP 22, Université Montpellier II, Place E. Bataillon, 34095 Montpellier Cedex 5, France.
3 CRBA CNRS UMR 5473, Université Montpellier I, Faculté de Pharmacie, 15 Av. Charles Flahault, 34060 Montpellier, France.
4 Department of Parasitology, Biomedical Primate Research Centre, Postbox 3306, 2280 GH Rijswijk, Netherlands.
5 Fundacion Centro de Primates, Universidad del Valle, Cali, Colombia.
*   To whom correspondence should be addressed. E-mail: vial{at}univ-montp2.fr

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Statistical Model To Evaluate In Vivo Activities of Antimalarial Drugs in a Plasmodium cynomolgi-Macaque Model for Plasmodium vivax Malaria.
C. H. M. Kocken, E. J. Remarque, M. A. Dubbeld, S. Wein, A. van der Wel, R. J. Verburgh, H. J. Vial, and A. W. Thomas (2009)
Antimicrob. Agents Chemother. 53, 421-427
   Abstract »    Full Text »    PDF »
Inhibition of Plasmodium falciparum Choline Kinase by Hexadecyltrimethylammonium Bromide: a Possible Antimalarial Mechanism.
V. Choubey, P. Maity, M. Guha, S. Kumar, K. Srivastava, S. K. Puri, and U. Bandyopadhyay (2007)
Antimicrob. Agents Chemother. 51, 696-706
   Abstract »    Full Text »    PDF »
Potent Antihematozoan Activity of Novel Bisthiazolium Drug T16: Evidence for Inhibition of Phosphatidylcholine Metabolism in Erythrocytes Infected with Babesia and Plasmodium spp..
E. Richier, G. A. Biagini, S. Wein, F. Boudou, P. G. Bray, S. A. Ward, E. Precigout, M. Calas, J.-F. Dubremetz, and H. J. Vial (2006)
Antimicrob. Agents Chemother. 50, 3381-3388
   Abstract »    Full Text »    PDF »
Localization of the Phosphoethanolamine Methyltransferase of the Human Malaria Parasite Plasmodium falciparum to the Golgi Apparatus.
W. H. Witola, G. Pessi, K. El Bissati, J. M. Reynolds, and C. B. Mamoun (2006)
J. Biol. Chem. 281, 21305-21311
   Abstract »    Full Text »    PDF »
Pharmacological Properties of a New Antimalarial Bisthiazolium Salt, T3, and a Corresponding Prodrug, TE3.
O. Nicolas, D. Margout, N. Taudon, S. Wein, M. Calas, H. J. Vial, and F. M. M. Bressolle (2005)
Antimicrob. Agents Chemother. 49, 3631-3639
   Abstract »    Full Text »    PDF »
In Vivo Evidence for the Specificity of Plasmodium falciparum Phosphoethanolamine Methyltransferase and Its Coupling to the Kennedy Pathway.
G. Pessi, J.-Y. Choi, J. M. Reynolds, D. R. Voelker, and C. B. Mamoun (2005)
J. Biol. Chem. 280, 12461-12466
   Abstract »    Full Text »    PDF »
Quantification of Antimalarial Bisthiazolium Compounds and Their Neutral Bioprecursors in Plasma by Liquid Chromatography-Electrospray Mass Spectrometry.
O. Nicolas, C. Farenc, M. Calas, H. J. Vial, and F. Bressolle (2005)
Clin. Chem. 51, 593-602
   Abstract »    Full Text »    PDF »
A choline "vacuum cleaner".
V. L. Lew (2004)
Blood 104, 3006-3007
   Full Text »    PDF »
Characterization of the choline carrier of Plasmodium falciparum: a route for the selective delivery of novel antimalarial drugs.
G. A. Biagini, E. M. Pasini, R. Hughes, H. P. De Koning, H. J. Vial, P. M. O'Neill, S. A. Ward, and P. G. Bray (2004)
Blood 104, 3372-3377
   Abstract »    Full Text »    PDF »
Prodrugs of bisthiazolium salts are orally potent antimalarials.
H. J. Vial, S. Wein, C. Farenc, C. Kocken, O. Nicolas, M. L. Ancelin, F. Bressolle, A. Thomas, and M. Calas (2004)
PNAS 101, 15458-15463
   Abstract »    Full Text »    PDF »
Unraveling the Mode of Action of the Antimalarial Choline Analog G25 in Plasmodium falciparum and Saccharomyces cerevisiae.
R. Roggero, R. Zufferey, M. Minca, E. Richier, M. Calas, H. Vial, and C. Ben Mamoun (2004)
Antimicrob. Agents Chemother. 48, 2816-2824
   Abstract »    Full Text »    PDF »
A pathway for phosphatidylcholine biosynthesis in Plasmodium falciparum involving phosphoethanolamine methylation.
G. Pessi, G. Kociubinski, and C. B. Mamoun (2004)
PNAS 101, 6206-6211
   Abstract »    Full Text »    PDF »
The Plasmodium falciparum PfGatp is an Endoplasmic Reticulum Membrane Protein Important for the Initial Step of Malarial Glycerolipid Synthesis.
T. C. Santiago, R. Zufferey, R. S. Mehra, R. A. Coleman, and C. B. Mamoun (2004)
J. Biol. Chem. 279, 9222-9232
   Abstract »    Full Text »    PDF »
Antimalarial drug discovery: old and new approaches.
P. J. Rosenthal (2003)
J. Exp. Biol. 206, 3735-3744
   Abstract »    Full Text »    PDF »
Heme Binding Contributes to Antimalarial Activity of Bis-Quaternary Ammoniums.
G. A. Biagini, E. Richier, P. G. Bray, M. Calas, H. Vial, and S. A. Ward (2003)
Antimicrob. Agents Chemother. 47, 2584-2589
   Abstract »    Full Text »    PDF »
Potent Inhibitors of Plasmodium Phospholipid Metabolism with a Broad Spectrum of In Vitro Antimalarial Activities.
M. L. Ancelin, M. Calas, V. Vidal-Sailhan, S. Herbute, P. Ringwald, and H. J. Vial (2003)
Antimicrob. Agents Chemother. 47, 2590-2597
   Abstract »    Full Text »    PDF »
In Vivo Antimalarial Activities of Mono- and Bis Quaternary Ammonium Salts Interfering with Plasmodium Phospholipid Metabolism.
M. L. Ancelin, M. Calas, A. Bonhoure, S. Herbute, and H. J. Vial (2003)
Antimicrob. Agents Chemother. 47, 2598-2605
   Abstract »    Full Text »    PDF »
EXPERIMENTAL INFECTION OF THE OLIVE BABOON (PAPIO ANUBIS) WITH PLASMODIUM KNOWLESI: SEVERE DISEASE ACCOMPANIED BY CEREBRAL INVOLVEMENT.
H. OZWARA, J. A. M. LANGERMANS, J. MAAMUN, I. O. FARAH, D. S. YOLE, J. M. MWENDA, H. WEILER, and A. W. THOMAS (2003)
Am J Trop Med Hyg 69, 188-194
   Abstract »    Full Text »    PDF »
Glucosamine Inhibits Inositol Acylation of the Glycosylphosphatidylinositol Anchors in Intraerythrocytic Plasmodium falciparum.
R. S. Naik, G. Krishnegowda, and D. C. Gowda (2003)
J. Biol. Chem. 278, 2036-2042
   Abstract »    Full Text »    PDF »
New Drug Class for Malaria on the Horizon?.
(2002)
Journal Watch Infectious Diseases 2002, 16
   Full Text »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)